https://www.jpost.com/health-science/covid-90-percent-of-patients-treated-with-new-israeli-drug-discharged-in-5-days-675961
"The main goal of this study was to verify that the drug is safe," Prof. Nadir Arber said. The principal investigator was identified as Greece's coronavirus commissioner, Prof. Sotiris Tsiodras. The new therapeutic works by suppressing cytokine reaction using the CD24 protein.
